UNJHAFORPharmaceuticals
Unjha Formulations Ltd — PE Ratio & Valuation Analysis
₹20.29
-1.10%
Current P/E10.74xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E38.3x71.9% below avg
✅
66.2% Discount to Industry
UNJHAFOR P/E 10.74x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹0.91 | ₹25 | 27.5x |
| 2024 | ₹0.62 | ₹30 | 49x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Unjha Formulations Ltd Valuation
Unjha Formulations Ltd (UNJHAFOR) currently trades at 10.74x earnings. The Pharmaceuticals sector average PE is 31.77x. UNJHAFOR is trading at a discount to peers — may indicate relative value. Historically, UNJHAFOR has traded at an average PE of 38.3x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
13.97%
Dividend Yield
0.00%
More on Unjha Formulations Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.